1. Staging criteria for lung cancer and the usual approach
  2. What KRAS inhibitors are available?
  3. What are the trials that established these?
  4. New breakthroughs?
  5. Other considerations
Session date: 
05/28/2026 - 8:00am to 9:00am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Shree Bose, MD, PhD